Mapi Collaborates With YPrime to Deploy eCOA Solutions
LONDON, July 17, 2017 - Mapi, the developer of Linguistic Validation and provider of Clinical Outcome Assessments collaborates with YPrime, the clinical research technology provider, to streamline the deployment of validated assessments migrated onto YPrime's eCOA platform.
Mapi Language services and YPrime are leveraging cloud level integrations between technology platforms to establish an operational interface between Mapi's ISO 17100 certified process and YPrime's eCOA platform facilitating Linguistic Validations and direct screenshot reviews.
The collaboration will also bring integration for Mapi to directly develop and validate eCOAs on YPrime's platform eliminating the manual versioning and migrated questionnaire processes for new “born on eCOA” questionnaires. The cloud facilitated integration process helps with migration integrity of paper originated COAs.
"Working with MAPI is part of YPrime's strategy to simplify access and expedite start-up timelines to eCOA implementation for research organizations across the industry," said Mark Maietta, Chief Commercial Officer of YPrime. "We are thrilled about the opportunity to align our advanced platform with the largest provider of Patient-Centered Outcome instruments in this initiative. With established benefits in user experience, data quality and regulatory acceptance of eCOA solutions, I am confident this alliance will accelerate the already-burgeoning eCOA market adoption."
The new process will reduce the Linguistic Validation cycle and accelerate deployment enabling quicker “first patient in” timelines. Additionally, the alliance enables real time collaboration reducing review and correction cycles. The entire process tightly follows Mapi's ISO 17100 Certification and offers multi-language simultaneous development of validated eCOAs on YPrime's eCOA platform.
Press contact: Media@mapigroup.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
